Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

General Thoracic and Cardiovascular Surgery is a pivotal academic journal dedicated to the rapidly evolving fields of thoracic and cardiovascular surgery. Published by SPRINGER JAPAN KK, this journal serves as a vital resource for clinicians, researchers, and medical professionals seeking insights into current practices, innovative techniques, and groundbreaking research. With an ISSN of 1863-6705 and an E-ISSN of 1863-6713, it has established a prominent presence in the academic community, demonstrated by its impressive ranking in the Q3 category for Cardiology and Cardiovascular Medicine and Surgery in 2023. The journal’s standards ensure high-quality, peer-reviewed articles that facilitate knowledge exchange and drive advancements in the field. Although it operates without open access, it remains accessible through library subscriptions and institutional affiliations. Covering a broad span of research from 2007 to 2024, General Thoracic and Cardiovascular Surgery is committed to enlightening its audience with findings that have substantial implications for clinical practices and patient outcomes.

HEAD AND NECK: JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, published by Wiley, is a leading academic journal dedicated to advancing the field of otorhinolaryngology. With an impressive impact factor and ranked #5 out of 123 in the field according to Scopus, this journal serves as a premier platform for researchers, clinicians, and students alike to share and gain insights into cutting-edge developments related to head and neck sciences. With publication spanning from 1989 to 2024, it enjoys a Q1 ranking in the otorhinolaryngology category, reflecting its high quality and significant contribution to the scientific community. The journal is crucial for those aiming to stay at the forefront of research and clinical practices in this highly specialized area. This combination of rigorous peer review and a focus on both practical and experimental studies make HEAD AND NECK an essential resource for anyone involved in the healthcare and research sectors pertaining to the head and neck.

Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.

The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.

South Asian Journal of Cancer, published by GEORG THIEME VERLAG KG, is a pivotal platform for research in the fields of oncology and cancer research. Established in 2012 and operating under an Open Access model, this journal aims to disseminate high-quality, peer-reviewed articles that address crucial developments in cancer treatment, prevention, and research, particularly within the South Asian context. Despite its young history, the journal has been positioned within the Q4 quartile for both Cancer Research and Oncology, and while current Scopus rankings indicate it resides in the lower percentiles, its commitment to amplifying regional voices and research is invaluable. With its headquarters in Stuttgart, Germany, and a global readership, South Asian Journal of Cancer is dedicated to enhancing collaboration among researchers, healthcare professionals, and students, fostering a space for innovative ideas and advancements in cancer care as we progress through to 2024.

PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.

Clinical Lymphoma Myeloma & Leukemia is a prestigious journal dedicated to the study and treatment of hematologic malignancies, offering a vital platform for researchers and healthcare professionals in the fields of oncology, hematology, and cancer research. Published by CIG MEDIA GROUP, LP, this journal has established itself as a crucial resource since its inception in 2010, with a continuous commitment to disseminating knowledge until at least 2024. With an impact factor that objectively reflects its influence, it is rated in Q3 quartiles in both Cancer Research and Hematology as well as in Oncology as of 2023. Researchers can access a wealth of articles and studies that explore various dimensions of lymphoma, myeloma, and leukemia, thus fostering an environment of collaboration and innovation. Although it currently does not offer full open access, its extensive archive and rigorous peer-review process ensure the publication of high-quality research, making it an essential resource for anyone dedicated to advancing the science and practice of treating blood cancers.

Techniques in Coloproctology is an esteemed, peer-reviewed journal hosted by SPRINGER-VERLAG ITALIA SRL, dedicated to advancing the fields of gastroenterology and surgery with a specific focus on innovative techniques and clinical practices in coloproctology. Since its inception in 1998, the journal has been instrumental in fostering knowledge and research dissemination, exemplified by its current recognition in the 2023 quartiles as Q2 in Gastroenterology and Q1 in Surgery, reflecting its impact and relevance within the medical community. With a notable Scopus ranking of #73/551 in Medicine - Surgery and #53/167 in Medicine - Gastroenterology, it serves as a vital resource for practitioners, researchers, and students alike. Although it is not an open-access journal, the journal provides a unique platform for interdisciplinary collaboration and the sharing of cutting-edge findings, pivotal to the ongoing evolution of surgical techniques. As it continues to publish high-quality research through 2024 and beyond, the journal remains at the forefront of improving outcomes in coloproctological practices.

The Journal of Gastrointestinal Oncology, published by AME Publishing Company, is a leading open-access journal that focuses on the complex interplay between gastroenterology and oncology. Established in 2012 and converging into a reputable academic platform through 2024, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and management of gastrointestinal cancers. With an ISSN of 2078-6891 and an E-ISSN of 2219-679X, this journal presents articles that are rigorously peer-reviewed, ensuring high-quality content that meets the demands of the scientific community. Despite its current categorization in the Q3 quartile for both Gastroenterology and Oncology as of 2023, it consistently strives to improve its impact and relevance, reflected in its Scopus rankings and percentile metrics. Publishing noteworthy research, reviews, and case studies, the Journal of Gastrointestinal Oncology is instrumental in addressing significant challenges in the field, making it a must-read for those dedicated to advancing knowledge and practice in gastrointestinal oncology.